Insider · CIK 0001976455
Andrew Aromando
officer
Files at ONCY (ONCOLYTICS BIOTECH INC). First filing Feb 13, 2026, latest Feb 13, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$25k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ONCY: ONCOLYTICS BIOTECH INC
ONCYOct 9, 2026 · close 0.56
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | ONCOLYTICS BIOTECH INC | $25k 29,600 shares | +116% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | ONCY ONCOLYTICS BIOTECH INC | AGrant or award Stock Optionderivative | +260,000 | $0.00 | $0 | 260,000 | Jun 3, 2026 |
| Feb 11, 2026 | ONCY ONCOLYTICS BIOTECH INC | POpen-market purchase Common Shares | +29,600 | $0.86 | $25k | 55,100 | Feb 13, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.